Clinical Trial

Role of Bumetanide in Treatment of Autism

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Role of bumetanide in Autism
Trial Details
NCT Number NCT04766177
Lead Sponsor Sherief Abd-Elsalam
Conditions Autism
Enrollment 80 participants
Start Date 2021-01-01
Primary Completion 2030-12-01 (estimated)
Study Completion 2030-12-01 (estimated)
Updated on ClinicalTrials.gov 2021-02-23